| | | | | | | | | | |
|
|
| Dockets Entered
On September 27, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
| 2004N-0234
|
| Annual Guidance Agenda
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
|
|
| 2005P-0377
|
| Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
|
|
|
| 2006E-0006
|
| Patent Extension Application for Lyrica (pregabalin), U.S. Patent No. 6,197,819
|
|
|
| 2006M-0148
|
| P040028 - LUMA Cervical Imaging System
|
|
|
| 2006M-0161
|
| Premarket Approval for Ceralas I Laser System and Ceralink Slit Lamp Adapter by QLT USA, Inc., P050021
|
|
|
| 2006M-0162
|
| Quantel Activis Laser and ZSL30 ACT, and HSBMBQ ACT Slit Lamp Adapters by - QLT USA, Inc.
|
|
|
| 2006M-0193
|
| P040033 - Birmingham Hip Resurfacing (BHR) System
|
|
|
| 2006M-0199
|
| P030008/S004 - WaveLight ALLEGRETTO WAVE Excimer Laser System
|
|
|
| 2006M-0200
|
| P050012 - DexCom STS Continuous Glucose Monitoring System
|
|
|
| 2006M-0235
|
| P050047 - Juvederm 24HV, Juvederm 30, and Juvederm 30HV Gel Implants
|
|
|
| 2006M-0264
|
| Premarket Approval: P040052 -MonoPrep Pap Test (MPPT)
|
|
|
| 2006N-0107
|
| FDA-Regulated Products Containing Nanotechnology Materials
|
|
|
| 2006N-0283
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Survey of Physicians Perceptions of the Impact of Early Risk Communication about Medical Products
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
| 2006P-0394
|
| To take regulatory action to revise the labeling requirements for eggs sold in the United States
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
| RPT 20
|
| University of Texas Health Science Center at San Antonio
|
| Vol #:
|
| 19
|
|
|
| 2004N-0234
|
| Annual Guidance Agenda
|
|
|
| EC 4
|
| Valley High School
|
| Vol #:
|
| 1
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
| PDN 1
|
| FDA to Coalition for Mercury-free Drugs (CoMeD)
|
| Vol #:
|
| 1
|
|
|
| 2005H-0271
|
| Civil Money Penalty: TMJ Implants, Inc.
|
|
|
| MO 19
|
| TMJ Implants, Inc.
|
| Vol #:
|
| 6
|
|
|
| 2005N-0403
|
| Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
|
|
|
|
|
|
| EC 2
|
| Animal Health Institute
|
| Vol #:
|
| 3
|
|
|
| 2005P-0377
|
| Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
|
|
| | | | | | | | |
|
|
| SUP 17
|
| Department of the Planet Earth
|
| Vol #:
|
| 5
|
|
|
| 2006E-0006
|
| Patent Extension Application for Lyrica (pregabalin), U.S. Patent No. 6,197,819
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0148
|
| P040028 - LUMA Cervical Imaging System
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0161
|
| Premarket Approval for Ceralas I Laser System and Ceralink Slit Lamp Adapter by QLT USA, Inc., P050021
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0162
|
| Quantel Activis Laser and ZSL30 ACT, and HSBMBQ ACT Slit Lamp Adapters by - QLT USA, Inc.
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0193
|
| P040033 - Birmingham Hip Resurfacing (BHR) System
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0199
|
| P030008/S004 - WaveLight ALLEGRETTO WAVE Excimer Laser System
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0200
|
| P050012 - DexCom STS Continuous Glucose Monitoring System
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0235
|
| P050047 - Juvederm 24HV, Juvederm 30, and Juvederm 30HV Gel Implants
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006M-0264
|
| Premarket Approval: P040052 -MonoPrep Pap Test (MPPT)
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006N-0107
|
| FDA-Regulated Products Containing Nanotechnology Materials
|
|
|
| C 4
|
| C. Pelsor
|
| Vol #:
|
| 1
|
|
|
| C 5
|
| R. Knablin
|
| Vol #:
|
| 1
|
|
|
| 2006N-0283
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Survey of Physicians Perceptions of the Impact of Early Risk Communication about Medical Products
|
|
|
|
|
|
| C 2
|
| Scientific Advantage, LLC
|
| Vol #:
|
| 1
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
| SUP 3
|
| ViroPharma Incorporated (ViroPharma)
|
| Vol #:
|
| 1
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
|
|
|